PIM
SVA

Platinum Investment Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Platinum Investment Management’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-30,400
Closed -$159K – 92
2015
Q2 		$159K Buy
+30,400
New +$161K ﹤0.01% 84

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Platinum Investment Management's SVA Position: Q3 2015 in Review

Platinum Investment Management sold out of Sinovac Biotech, Ltd (SVA) in Q3 2015, closing a stake of 30,400 shares — an estimated $159K sold.

Platinum Investment Management first reported a position in SVA in Q2 2015 and held it in 1 quarter. The position peaked at $159K in Q2 2015. 37 funds tracked by Wall St. Rank hold SVA as of Q3 2015.

  • Platinum Investment Management reported no remaining Sinovac Biotech, Ltd position as of Q3 2015 after selling out during the quarter.
  • Platinum Investment Management sold 30,400 Sinovac Biotech, Ltd shares in Q3 2015, an estimated $159K.
  • Platinum Investment Management first reported a position in Sinovac Biotech, Ltd in Q2 2015 and held it in 1 quarter.
  • Platinum Investment Management's Sinovac Biotech, Ltd position peaked at $159K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2015.

Based on Platinum Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.